Quality of life in children participating in a non-selective INR self-monitoring VKA-education programme.
Pascal Amedro, Fanny Bajolle, Helena Bertet...
https://pubmed.ncbi.nlm.nih.gov/29100908/Actively Recruiting
Led by University Hospital, Bordeaux · Updated on 2026-07-08
192
Participants Needed
6
Research Sites
N/A
Total Duration
Researchers are evaluating a home-based neuro-cardiac rehabilitation program for children, teens, and young adults aged 8 to 25 years with rare and complex congenital heart disease CHD. The study aims to address common long-term challenges in this population, including neurodevelopmental difficulties, mental health issues, and reduced exercise capacity, which negatively impact quality of life. This randomized controlled trial compares the new integrative program combining physical and psychological rehabilitation to the standard cardiology care. The intervention group will participate in a 12-week program that includes two weekly sessions of adapted physical exerciseone in person at home and one via videoconferencefocusing on bicycle training and other activities. Additionally, they will engage in computerized cognitive training sessions and telehealth psycho-education for emotional regulation and executive functioning, involving both patients and their parents. The control group will receive standard cardiology care without additional rehabilitation activities. Participants will be assessed over 12 months for changes in health-related quality of life, cognitive and mental health outcomes, and physical and cardiovascular measures. Assessments include standardized questionnaires, neuropsychological tests, and cardiopulmonary exercise tests. Parents will be actively involved and receive personalized feedback and educational resources. The study will measure the effectiveness of this comprehensive program to potentially improve care for children with rare CHD.
CONDITIONS
Neuro-cardiac Rehabilitation in Youth With Congenital Heart Disease (QUALINEUROREHAB)
P
Pascal AMEDRO, MD,PhD
J
Johanna CALDERON, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital, Bordeaux
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants in the intervention group engage in a 12-week home-based program involving twice-weekly physical exercise sessions (one in person and one via videoconference), computerized cognitive training, and telehealth psycho-education sessions for patients and parents.
Weekly sessions (in person and videoconference)
Duration - 12 weeks
Participants in the control group receive the usual cardiology care without additional rehabilitation interventions, including regular consultations and follow-up.
Routine cardiology visits
Duration - 12 months
All participants are monitored over 12 months to assess changes in quality of life, cognitive and mental health, and physical and cardiovascular outcomes through questionnaires, tests, and exercise assessments.
Assessments at baseline and 12 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Pascal Amedro, Fanny Bajolle, Helena Bertet...
https://pubmed.ncbi.nlm.nih.gov/29100908/Arthur Gavotto, Helena Huguet, Marie-Christine Picot...
https://pubmed.ncbi.nlm.nih.gov/32909919/P Amedro, M C Picot, S Moniotte...
https://pubmed.ncbi.nlm.nih.gov/26638054/Johanna Calderon, David Wypij, Valerie Rofeberg...
https://pubmed.ncbi.nlm.nih.gov/32827526/Oscar Werner, Hamouda Abassi, Kathleen Lavastre...
https://pubmed.ncbi.nlm.nih.gov/31262673/Michael Meyer, Leon Brudy, Angeles Fuertes-Moure...
https://pubmed.ncbi.nlm.nih.gov/33516681/Johanna Calderon, David C Bellinger, Catherine Hartigan...
https://pubmed.ncbi.nlm.nih.gov/30782877/Jan Müller, Birgit Böhm, Sebastian Semsch...
https://pubmed.ncbi.nlm.nih.gov/23345176/Hamouda Abassi, Fanny Bajolle, Oscar Werner...
https://pubmed.ncbi.nlm.nih.gov/33069639/P Amedro, R Dorka, S Moniotte...
https://pubmed.ncbi.nlm.nih.gov/26024647/University Hospital, Bordeaux
Lead Sponsor